ERC PHARMA ALPHA
ActiveSummary
The computed 12-month bankruptcy probability of ERC PHARMA ALPHA is 1.7% (moderate). The 2024 annual accounts show equity of €529k and a net result of €-63k. Equity is growing by ~18.8% per year across the filed fiscal years. Its solvency ranks better than 66% of 26043 sector peers (fiscal year 2024). The company has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
Axes · tick = 2023
Profitability11▼-72
Solvency77▼-18
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
1.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €22k at 30 days only on tighter terms
Liquidity ample (current ratio 2.02 against 3.15 in 2023; short-term debt: 48.2% and cash: 4.2% of total assets), and 48.2% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
51.8%
Return on assets
-6.2%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-08-2025, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
26 d late
2023
138 d late
2022
56 d late
2021
23 d late
2020
17 d late
2019
28 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-63k
2023 · €98k
2018: €40k
2019: €35k▼ -12.7% vs 2018
2020: €87k▲ +146% vs 2019
2021: €149k▲ +71.6% vs 2020highest in 7 years
2022: €98k▼ -34.2% vs 2021
2023: €98k▼ -0.2% vs 2022
2024: €-63k▼ -165% vs 2023lowest in 7 years
2018 → 2024
Working capital
€501k▼ 9.0%
2023 · €551k
2018: €156k
2019: €97k▼ -37.9% vs 2018lowest in 7 years
2020: €189k▲ +94.3% vs 2019
2021: €355k▲ +87.9% vs 2020
2022: €433k▲ +22.1% vs 2021
2023: €551k▲ +27.1% vs 2022highest in 7 years
2024: €501k▼ -9.0% vs 2023
2018 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€277k-€426k▲ 53.6%€495k▲ 16.1%€592k▲ 19.7%€529k▼ 10.7%
2020: €277klowest in 5 years
2021: €426k▲ +53.6% vs 2020
2022: €495k▲ +16.1% vs 2021
2023: €592k▲ +19.7% vs 2022highest in 5 years
2024: €529k▼ -10.7% vs 2023
Operating result€122k-€195k▲ 59.8%€132k▼ 32.1%€135k▲ 2.1%€-62k
2020: €122k
2021: €195k▲ +59.8% vs 2020highest in 5 years
2022: €132k▼ -32.1% vs 2021
2023: €135k▲ +2.1% vs 2022
2024: €-62k▼ -146% vs 2023lowest in 5 years
Net result€87k-€149k▲ 71.6%€98k▼ 34.2%€98k▼ 0.2%€-63k
2020: €87k
2021: €149k▲ +71.6% vs 2020highest in 5 years
2022: €98k▼ -34.2% vs 2021
2023: €98k▼ -0.2% vs 2022
2024: €-63k▼ -165% vs 2023lowest in 5 years
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2024: a loss of €62k after €135k in 2023, the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.02M
Fixed assets
€28k ▼ 32.9%
Current assets
€993k ▲ 23.1%
Equity and liabilities €1.02M
Equity
€529k ▼ 10.7%
Debt
€491k ▲ 92.0%
Debt's share of the balance-sheet total rises from 30.2% to 48.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€-48k▼
2023 · €149k
Cash flow
€-49k▼
2023 · €112k
Current ratio
2.02▼
2023 · 3.15
Quick ratio
1.58▼
2023 · 2.74
Debt to equity
0.93▲
2023 · 0.43
ROE
-11.9%▼
2023 · 16.5%
ROA
-6.2%▼
2023 · 11.5%
Interest coverage
-30.91▼
2023 · 105.69
Debt ≤ 1 year
€491k▲
2023 · €256k
Staff costs
€291k▲
2023 · €261k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 48 lines
Balance sheet
Code20232024
Assets
Total assets20/58€848k€1.02M▲
Fixed assets21/28€42k€28k▼
Tangible fixed assets22/27€39k€26k▼
Plant, machinery and equipment23€5k€3k▼
Furniture and vehicles24€941€186▼
Other tangible fixed assets26€33k€22k▼
Financial fixed assets28€2k€2k=
Current assets29/58€806k€993k▲
Stocks and contracts in progress3€106k€217k▲
Stocks30/36€106k€217k▲
Amounts receivable within one year40/41€611k€733k▲
Trade receivables40€99k€19k▼
Other amounts receivable41€512k€714k▲
Cash at bank and in hand54/58€87k€43k▼
Deferred charges and accrued income490/1€2k€396▼
Equity and liabilities
Total equity and liabilities10/49€848k€1.02M▲
Equity10/15€592k€529k▼
Contributions10/11€19k€19k=
Reserves13€170k€170k=
Non-distributable reserves130/1€11k€11k=
Reserves not available under the articles1311€11k€11k=
Distributable reserves133€159k€159k=
Profit (loss) carried forward14€404k€341k▼
Amounts payable17/49€256k€491k▲
Amounts payable within one year42/48€256k€491k▲
Financial debts43€3€40k▲
Credit institutions430/8€3€40k▲
Trade debts44€205k€395k▲
Suppliers440/4€205k€395k▲
Taxes, remuneration and social security45€46k€56k▲
Taxes450/3€10k€20k▲
Remuneration and social security454/9€35k€36k▲
Other amounts payable47/48€5k-
Income statement
Code20232024
Remuneration, social security and pensions62€261k€291k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k€14k▼
Other operating charges640/8€3k€5k▲
Gross operating margin9900€413k€248k▼
Operating profit (loss)9901€135k€-62k▼
Financial income75/76B€340€0▼
Recurring financial income75€340€0▼
Financial charges65/66B€1k€2k▲
Recurring financial charges65€1k€2k▲
Profit (loss) for the period before taxes9903€134k€-63k▼
Income taxes67/77€36k-
Profit (loss) for the period9904€98k€-63k▼
Profit (loss) for the period to be appropriated9905€98k€-63k▼
Appropriation of the result
Profit (loss) to be appropriated9906€404k€341k▼
Profit (loss) brought forward from the previous period14P€306k€404k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €183k | €241k | €261k | €291k | ▲ 11.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €47k | €19k | €17k | €14k | €14k | ▼ 2.9% |
| Other operating charges640/8 | - | €499 | €1k | €3k | €5k | ▲ 76.5% |
| Gross operating margin9900 | €365k | €397k | €392k | €413k | €248k | ▼ 39.9% |
| Operating profit (loss)9901 | €122k | €195k | €132k | €135k | €-62k | ▼ 146% |
| Financial income75/76B | - | €705 | €494 | €340 | €0 | ▼ 99.9% |
| Recurring financial income75 | €2k | €705 | €494 | €340 | €0 | ▼ 99.9% |
| Financial charges65/66B | - | €1k | €910 | €1k | €2k | ▲ 9.8% |
| Recurring financial charges65 | €2k | €1k | €910 | €1k | €2k | ▲ 9.8% |
| Profit (loss) for the period before taxes9903 | €122k | €194k | €132k | €134k | €-63k | ▼ 147% |
| Income taxes67/77 | €35k | €46k | €34k | €36k | - | - |
| Profit (loss) for the period9904 | €87k | €149k | €98k | €98k | €-63k | ▼ 165% |
| Profit (loss) for the period to be appropriated9905 | €87k | €149k | €98k | €98k | €-63k | ▼ 165% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €460k | €599k | €840k | €848k | €1.02M | ▲ 20.3% |
| Fixed assets21/28 | €88k | €71k | €61k | €42k | €28k | ▼ 32.9% |
| Tangible fixed assets22/27 | €86k | €69k | €59k | €39k | €26k | ▼ 34.9% |
| Plant, machinery and equipment23 | - | €3k | €7k | €5k | €3k | ▼ 35.7% |
| Furniture and vehicles24 | - | €11k | €8k | €941 | €186 | ▼ 80.2% |
| Other tangible fixed assets26 | - | €55k | €44k | €33k | €22k | ▼ 33.5% |
| Financial fixed assets28 | €2k | €2k | €2k | €2k | €2k | = |
| Current assets29/58 | €371k | €528k | €779k | €806k | €993k | ▲ 23.1% |
| Stocks and contracts in progress3 | €141k | €131k | €139k | €106k | €217k | ▲ 104% |
| Stocks30/36 | - | €131k | €139k | €106k | €217k | ▲ 104% |
| Amounts receivable within one year40/41 | €71k | €95k | €101k | €611k | €733k | ▲ 19.8% |
| Trade receivables40 | - | €95k | €92k | €99k | €19k | ▼ 81.2% |
| Other amounts receivable41 | - | €185 | €9k | €512k | €714k | ▲ 39.3% |
| Cash at bank and in hand54/58 | €157k | €298k | €533k | €87k | €43k | ▼ 50.7% |
| Deferred charges and accrued income490/1 | - | €4k | €6k | €2k | €396 | ▼ 78.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €460k | €599k | €840k | €848k | €1.02M | ▲ 20.3% |
| Equity10/15 | €277k | €426k | €495k | €592k | €529k | ▼ 10.7% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | €199k | €199k | €170k | €170k | €170k | = |
| Non-distributable reserves130/1 | - | €11k | €11k | €11k | €11k | = |
| Reserves not available under the articles1311 | - | €11k | €11k | €11k | €11k | = |
| Distributable reserves133 | - | €188k | €159k | €159k | €159k | = |
| Profit (loss) carried forward14 | €60k | €209k | €306k | €404k | €341k | ▼ 15.6% |
| Amounts payable17/49 | €182k | €174k | €345k | €256k | €491k | ▲ 92.0% |
| Amounts payable within one year42/48 | €182k | €174k | €345k | €256k | €491k | ▲ 92.0% |
| Financial debts43 | - | - | - | €3 | €40k | ▲ 1,345,558% |
| Credit institutions430/8 | - | - | - | €3 | €40k | ▲ 1,345,558% |
| Trade debts44 | €92k | €119k | €263k | €205k | €395k | ▲ 92.9% |
| Suppliers440/4 | - | €119k | €263k | €205k | €395k | ▲ 92.9% |
| Taxes, remuneration and social security45 | - | €48k | €48k | €46k | €56k | ▲ 22.2% |
| Taxes450/3 | - | €24k | €15k | €10k | €20k | ▲ 92.9% |
| Remuneration and social security454/9 | - | €23k | €33k | €35k | €36k | ▲ 1.6% |
| Other amounts payable47/48 | - | €7k | €35k | €5k | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €87k | €149k | €98k | €98k | €-63k | ▼ 165% |
| + Depreciation and write-downs630 | €47k | €19k | €17k | €14k | €14k | ▼ 2.9% |
| Operating cash flow (approximation) | €133k | €168k | €115k | €112k | €-49k | ▼ 144% |
| Investment in fixed assets (approximation) | - | €-2k | €-8k | €6k | €0 | ▼ 100% |
| Change in cash | - | €141k | €235k | €-446k | €-44k | ▲ 90.1% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
26-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 26 days late
2024
31-12
Financial
Weakest financial yearnet €-63k
Net result drops to €-63k, the lowest in the series.
16-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 138 days late
2023
31-12
Financial
Equity above €500kEq €592k ▲19.7%
6 profitable years in a row build equity to €592k.
25-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 56 days late
2022
23-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 23 days late
2021
31-12
Financial
Highest result since 2018net €149k ▲71.6%
Operating result €195k, net result €149k, both a record.
17-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 17 days late
2020
31-12
Financial
Equity above €200kEq €277k ▲39.9%
3 profitable years in a row build equity to €277k.
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 28 days late
2019
27-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 58 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 29 days late
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 29 days late
2016
27-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jette · 2 establishment units since 1996
Ground area
279 m²
Building footprint
270 m²
Volume, LiDAR
2,842 m³
2 parcels, Brussels · tallest building 16.9 m, ±5 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
2 establishment units
Leopold I straat 316, 1090 Jette
since 19962.228.134.837
Alsembergsesteenweg 623, 1180 Ukkel
since 20112.228.135.134
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21616A0247/00V000 | Brussels | 150 m² | 1 · 151 m² | 14.7 m · 3 fl. |
| 21464D0128/00Y006 | Brussels | 129 m² | 1 · 119 m² | 16.9 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteJette2.228.134.837
Similar companies · same sector, comparable size
CORUM
BE 0440.033.372
Gent · Eq €528,971
Pharmacie de Rendeux
BE 0466.892.375
Rendeux · Eq €529,882
APOTHEEK LISMONDE
BE 0454.430.053
Schilde · Eq €529,982
Pharmacie de Hérinnes
BE 0825.530.475
Pecq · Eq €528,039
APOTHEEK JUST PHARMA
BE 0441.570.130
Aalst · Eq €527,728
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,345 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded07-01-1997
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Contact
E-mail
pharmacie.zombek@dynaphar.beJette
Phone
02 425 74 42Jette
Phone
02 243 02 87Ukkel
Scores and ratios are computed by Checked and are not a credit decision.